Efgartigimod alfa–hyaluronidase significantly improves ocular symptoms in adults with ocular myasthenia gravis, according to phase 3 trial data.
The MarketWatch News Department was not involved in the creation of this content. Dr. Alexander Rivkin, a global pioneer in Non-Surgical Rhinoplasty, contributes to an award winning international ...
Huonslab said Wednesday that Hydizyme, its self-developed recombinant human hyaluronidase injection, is expected to be approved in the second half of this year. Huonslab, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results